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Abstract Adult neurons, which are terminally differen-
tiated cells, demonstrate substantial radioresistance. In
contrast, human neural stem cells (NSC), which have a
significant proliferative capacity, are highly sensitive to
ionizing radiation. Cranial irradiation that is widely used
for treatment of brain tumors may induce death of NSC and
further cause substantial cognitive deficits such as impair-
ing learning and memory. The main goal of our study was
to determine a mechanism of NSC radiosensitivity. We
observed a constitutive high-level expression of TRAIL-R2
in human NSC. On the other hand, ionizing radiation
through generation of reactive oxygen species targeted cell
signaling pathways and dramatically changed the pattern of
gene expression, including upregulation of TRAIL. A
significant increase of endogenous expression and secretion
of TRAIL could induce autocrine/paracrine stimulation of
the TRAIL-R2-mediated signaling cascade with activation
of caspase-3-driven apoptosis. Furthermore, paracrine
stimulation could initiate bystander response of non-tar-
geted NSC that is driven by death ligands produced by
directly irradiated NSC. Experiments with media transfer
from directly irradiated NSC to non-targeted (bystander)
NSC confirmed a role of secreted TRAIL for induction of a
death signaling cascade in non-targeted NSC. Subse-
quently, TRAIL production through elimination of
bystander TRAIL-R-positive NSC might substantially
restrict a final yield of differentiating young neurons.
Radiation-induced TRAIL-mediated apoptosis could be
partially suppressed by anti-TRAIL antibody added to the
cell media. Interestingly, direct gamma-irradiation of SK-
N-SH human neuroblastoma cells using clinical doses
(2–5 Gy) resulted in low levels of apoptosis in cancer cells
that was accompanied however by induction of a strong
bystander response in non-targeted NSC. Numerous pro-
tective mechanisms were involved in the maintenance of
radioresistance of neuroblastoma cells, including constitu-
tive PI3K-AKT over-activation and endogenous synthesis
of TGFb1. Specific blockage of these survival pathways
was accompanied by a dramatic increase in radiosensitivity
of neuroblastoma cells. Intercellular communication
between cancer cells and NSC could potentially be
involved in amplification of cancer pathology in the brain.
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STAT Signal transducers and activators of
transcription
TGFb Transforming growth factor beta
TGFb-R TGFb-receptor
TNFa Tumor necrosis factor alpha





Radiation therapy alone or in combination with chemo-
therapy is a standard modality for treatment of many types
of tumors, including cancers in the nervous system. Normal
adult neurons, which are terminally differentiated cells,
demonstrate a substantial radioresistance. In contrast,
neural stem and progenitor cells (NSC/NPC) having sig-
nificant proliferative capacities are highly sensitive to
ionizing radiation. Cranial irradiation used for treatment of
brain tumors may cause substantial cognitive deficits such
as impairing learning, attention and memory, which are
especially pronounced in children, due to inhibition of the
proliferation and death of neural stem cells (NSC) [1–6].
Ionizing irradiation generates reactive oxygen species
(ROS) that cause DNA damage and affect numerous cell
signaling pathways and the corresponding gene expression
followed by inhibition of cell proliferation, induction of the
DNA repair mechanisms and, finally, either cell survival or
cell death (via apoptosis, necrosis or mitotic catastrophe)
depending on a balance between cell survival and cell killing
mechanisms [7, 8]. Besides the primary induction of ROS in
the cell as a result of ionizing radiation, there are numerous
mechanisms that accelerate ROS/RNS production after
irradiation. These are dependent on modulation of the
mitochondrial functions or NADPH oxidase-1 activity [8, 9].
Consequently, directly irradiated cells can dramatically
change the regulation of gene expression by induction of
SOS programs, sharing multiple common features with a
general response to oxidative stress. Induction of gene
expression of proinflammatory cytokines (IL1b, TNFa, IL6,
IL17 and IL33) and COX2 directed by activation of the
transcription factors NF-jB, STAT3 and AP1 is a common
feature of different types of stress response and, furthermore,
a basis for the induction of a bystander response in non-
targeted cells induced by signaling machinery of directly
irradiated cells [10, 11]. Numerous investigations of the
radiation-induced bystander response of non-targeted cells
during the last two decades have dramatically changed the
paradigm of radiobiology concerning general regulation of
radiation response [9, 12, 13].
In the present study we investigate radiation-induced
effects in directly irradiated NSC or in human neuroblas-
toma cells with the subsequent induction of intercellular
communication and bystander response of non-targeted
NSC that could ultimately result in the death or inhibition
of differentiation of non-targeted cells.
Results
Radiation-induced death of human NSC
In human SOX2-positive, Nestin-positive neural stem/pro-
genitor cells (NSC) exposed to graded doses of c-irradiation
(2.5–10 Gy), there was the early (6 h after treatment) pro-
nounced activation of caspase-3 evaluated by downregulation
of the latent form of procaspase-3 (p32) and induction of
caspase3-dependent cleavage of PARP1 that was suppressed
by pan-caspase inhibitor zVAD-fmk (40 lM), rather than by a
necroptosis inhibitor Necrostatin-1 (40 lM) (Fig. 1a, b). Sur-
vival of irradiated NSC was substantially decreased (Fig. 1c),
while apoptotic levels of irradiated NSC (determined by PI
staining and FACS analysis as % cells in pre-G1 area) were
gradually increased 24–72 h after treatment in dose-dependent
manner (Fig. 1d). Proliferation and survival of human NSC is
critically dependent on several growth factors, FGF2, EGF and
IGF1 [14], which via the corresponding receptors induce the
PI3K–AKT and MAPK signaling cascades. LY294002, a
PI3K–AKT small molecule inhibitor, induced notable levels of
apoptosis in NSC and dramatically upregulated radiation-
induced apoptosis of NSC (Fig. 1e). Based on comparison of
levels of apoptosis and total cell death, it was evident that the
vast majority of irradiated NSC died via apoptotic pathways
(Fig. 1e). In general, death ofNSC was easily observed as early
as 6 h after irradiation by pronounced flotation of dying NSC
and decreased confluence of adherent cells.
Radiation-induced apoptosis in NSC is mediated
by the endogenous TRAIL/TRAIL-R2 expression
SOX2 and Nestin-positive NSC (Figs. 1a, 2a) were further
characterized by constitutively high level of TRAIL-R2 (a
synonym DR5) expression that was not further upregulated
upon c-irradiation (Fig. 2a); TRAIL-R1/DR4 expression
was not detectable in NSC. On the other hand, total levels of
p53-dependent TRAIL and Fas-Receptor [15, 16], but not
Fas-Ligand (Fas-L), were notably upregulated after irradia-
tion in parallel with an increase of p53 protein levels. These
changes were in concert with a substantial downregulation of
anti-apoptotic Survivin (Fig. 2a). Immunostaining and
FACS analysis further confirmed upregulation of total
TRAIL levels and the presence of constitutively high
TRAIL-R2 levels after irradiation of NSC (Fig. 2b).
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Apoptotic commitment was evident 6 h after irradiation, due
to downregulation of the latent pro-Caspase-8 that reflected
activation of the TRAIL-R2-mediated death signaling cas-
cade (Fig. 2a) followed by pro-Caspase-3 activation and
PARP1 cleavage (see Fig. 1b).
Furthermore, IKK-NF-jB and AKT activities (deter-
mined as levels of the corresponding phosphoproteins)
were substantially decreased after irradiation. Activities of
two MAPK’s, JNK and especially p38, were also
decreased, while ERK activity was relatively stable in
irradiated cells. Stat3 total levels were also relatively stable
(Fig. 2a). Combined treatment of NSC by irradiation in the
presence of specific small molecule inhibitors of cell sig-
naling pathways, U0126 (a MEK-ERK inhibitor),
SP600125 (a JNK inhibitor), SB203580 (a MAPK p38
inhibitor), BMS345541 (an IKK-NF-jB inhibitor),
LY294002 (a PI3K–AKT inhibitor), and Stat3-inhibitor-6
highlighted a prosurvival role for AKT and JNK activation
during radiation-induced apoptotic commitment of NSC
(Fig. 2a). Radiation-induced endogenous expression of
TRAIL in TRAIL-R2/DR5-positive NSC and almost neg-
ligible levels of endogenous Fas-L expression in these cells
allow us to suggest the TRAIL–TRAIL-R2 interaction as a
possible driver of radiation-induced death of NSC.
To further address a question about the functional sig-
nificance of TRAIL-R-mediated death signaling cascade in
human NSC, we used the exogenous recombinant TRAIL
(10–50 ng/ml). Even at high dose (50 ng/ml), TRAIL alone
only modestly increased PARP1 cleavage and induced
relatively low levels of apoptosis in NSC 24 after treatment
(Fig. 3a–c). As expected, a combination of TRAIL (50 ng/
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Fig. 1 Radiation-induced apoptosis in human neural stem cells
(NSC). a Confocal analysis of immunofluorescent images of NSC
was performed using monoclonal antibody against Nestin, an early
neuroprogenitor cell marker (red), and polyclonal antibody against
Sox2, a pluripotency marker (green). b Western blot analysis of
expression of pro-Caspase3 and PARP1 in human NSC 6 h after
treatment by increasing doses of c-irradiation. A universal caspase
inhibitor zVAD-fmk (40 lM) and an inhibitor of necroptosis,
Necrostatin (40 lM), were added 30 min before irradiation, as
indicated. Beta-Actin was used as a loading control. c Effect of c-
irradiation on survival of human NSC. Numbers of live cells attached
to fibronectin matrix were determined before irradiation at time point
0 and 48 h after treatment. Relative cell density (normalized to initial
cell density at time point 0) is indicated. d, e Cell cycle-apoptosis
analysis of human NSC after treatment by increasing doses of c-
radiation. A PI3K–AKT inhibitor LY294002 (40 lM) was added
30 min before irradiation. At indicated time points, cells were stained
by propidium iodide and analyzed by the flow cytometry. Pooled
results of four independent experiments are shown in d. Error bars
represent mean ± SD (p \ 0.05, Student’s t test); star indicates a
significant difference. A typical experiment is shown in e. TD means
levels of total cell death that were determined using Trypan blue
exclusion assay
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increased levels of apoptosis 24 h after treatment (Fig. 3a–
c). Caspase-3-mediated cleavage of PARP1 and TRAIL-
induced apoptosis were substantially blocked by zVAD-
fmk, a universal caspase inhibitor, rather than by Ne-
crostatin-1 (40 lM), a necroptosis inhibitor (Fig. 3a).
Interestingly, Necrostatin-1 also dramatically upregulated
AKT activity and, thereafter, further stabilized the Nanog
(an AKT target) protein level (Fig. 3a). It also provided an
increase in general survival functions in NSC. In contrast,
no significant effects of Necrostatin-1 were observed in the
regulation of MAPK’s signaling pathways (Fig. 3a). Levels
of RIP1, which is critical for the necroptotic signaling
cascade [17], were somewhat modulated after treatment of
NSC with TRAIL or Necrostatin-1 alone or in combina-
tions (Fig. 3A).
Similar to TRAIL and CHX treatment, a combination of
the exogenous TNFa and CHX could induce well
pronounced apoptosis in NSC (Fig. 3c). However, this
combination was able to induce both apoptotic (zVAD-
fmk-sensitive) and necrotic (Necrostatin-sensitive) death
pathways, while TRAIL in combination with CHX induced
mainly apoptosis that did not respond to Necrostatin-1
cotreatment (Suppl. Fig. 1A).
To further confirm a leading role of the endogenous
TRAIL upregulation (Fig. 4a) in radiation-induced apop-
tosis, we used human TRAIL ELISA kit (R&D Systems)
for detection of TRAIL levels in the media 16 h after c-
irradiation at 5 Gy (Fig. 4b). Two-fold increase in TRAIL
concentration was detected. Basal level of TRAIL in non-
treated media probably connected with excretion from dead
cells. Next we added inhibitory anti-TRAIL antibody
(50 lg/ml) to the culture media 30 min before irradiation.
This allowed us to partially suppress the TRAIL–TRAIL-
R2-mediated signaling cascade. Treatment with this
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Fig. 2 Proapoptotic and prosurvival signaling during radiation-
induced apoptosis in NSC. a Expression levels of indicated proteins
were determined using Western blot analysis. Beta-Actin was used as
a loading control. b Endogenous TRAIL and TRAIL-R2/DR5
expression was determined using specific immunostaining and FACS
analysis. For detection of total protein expression in NSC, cells were
fixed and permeabilized using FIX & PERM cell fixation and
permeabilization reagents, while detection of surface expression was
performed without permeabilization (not shown). Percentage of
positively stained cells with the corresponding levels of median
fluorescent intensity (MFI) are indicated. c NSC were c-irradiated in
the presence or in the absence (control with the vehicle solution,
0.1 % DMSO) of specific small molecule inhibitors of signaling
pathways: U0126 (MEK-ERK; 10 lM), SP600125 (JNK; 20 lM)
SB203580 (MAPK p38; 10 lM), IKK-NF-jB (BMS345541; 10 lM),
LY294002 (PI3K-AKT; 50 lM) and Stat3-inhibitor-6 (25 lM),
which were added to the media 30 min before irradiation. Cell
cycle—apoptosis analysis was performed using PI staining and FACS
analysis. Stars indicate a significant difference
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antibody resulted in escape from PARP1 cleavage
(Fig. 4c), increase of cell survival and inhibition of radia-
tion-induced apoptosis (Fig. 4d, e). Taken together, these
results highlight the key role for endogenously produced
TRAIL in the radiation-induced apoptosis of human NSC
in cell culture conditions. The exogenous Fas-L in com-
bination with CHX was also able to induce modest levels
of apoptosis in NSC (data not shown), due to low surface
expression of Fas-receptor, which, however, notably
increased after irradiation (Fig. 4f). The endogenous pro-
duction of Fas-L was insignificant. The exogenous pro-
duction of TNFa and Fas-L that potentially could target
NSC in vivo is located in microglial and glial cells [18, 19].
Beside TRAIL, TNFa and Fas-L, we further tested
several cytokines, growth factors and PGE2 as probable
candidates for intercellular communication before and after
c-irradiation of NSC. We demonstrated that TGFb1 could
modestly increase basal apoptotic levels in human NSC
24 h after treatment (Suppl. Fig. 1B), reflecting the pre-
sence of the corresponding receptors in NSC. Furthermore,
pretreatment with TGFb1 (5 ng/ml) before irradiation
further upregulated levels of radiation-induced apoptosis in
NSC (Suppl. Fig. 1C). Surprisingly, we did not observe
notable protective effects against radiation-induced apop-
tosis of NSC by IL1b and PGE2 (Suppl. Fig. 1C).
Radiation-induced bystander effects in NSC: analysis
of cell cycle and apoptosis in directly irradiated
and non-targeted cells
Media-transfer experiments from directly irradiated NSC
with upregulated endogenous production and secretion of
several cytokines, such as TRAIL, to non-irradiated native
NSC (Suppl. Fig. 2) allow us to detect induction/upregu-
lation of apoptosis in non-targeted cells. Relatively low,
but a well pronounced apoptosis was detected 24–48 h
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Fig. 3 Exogenous TRAIL/TRAIL-R2-induced apoptosis in NSC.
Effects of combined treatment with TRAIL and cycloheximide
(CHX) on the cell cycle and apoptosis of human NSC. a Western blot
analysis of indicated proteins was performed 6 h after treatment with
TRAIL (50 ng/ml), CHX (1 lg/ml), zVAD-fmk (40 lM), Necrostatin
(40 lM) alone or in combination. PARP1 cleavage was used as a
characteristic feature of Caspase3-mediated apoptosis. Beta-Actin
was used as a loading control. b, c Cell cycle-apoptosis analysis was
performed after treatment of human NSC with TRAIL, TNFa (50 ng/
ml) and CHX alone or in combination in the presence or in the
absence of pan-caspase inhibitor zVAD-fmk (40 lM). PI staining of
DNA and FACS analysis was performed 24–48 h after indicated
treatment. A typical experiment is presented in b; pooled results of
four independent experiments are shown in c. Error bars represent
mean ± SD (p \ 0.05, Student’s t test); star indicates a significant
difference
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after irradiated media transfer, demonstrating a twofold
increase compared to control (non-irradiated) media
transfer (Fig. 5a, b). Caspase-3-mediated cleavage of
PARP1 in bystander cells was also evident in these con-
ditions (Fig. 5c). In contrast, immortalized human fetal
astrocytes (IHFA) exhibited a strong radioresistance after
treatment with clinical doses of c-radiation (Fig. 5d, e).
These cells did not produce TRAIL or Fas-L upon irradi-
ation (data not shown) and were resistant to the exogenous
TRAIL/TRAIL-R- mediated apoptosis due to the absence
of surface TRAIL-R expression [20]. Furthermore, as
recently established, astrocytes lack functional DNA
damage response signaling that tightly correlated with their
radioresistance [21]. Thereafter, media transfer from irra-
diated IHFA did not notably upregulate apoptosis and did
not induce PARP1 cleavage in bystander NSC (Fig. 5d–f).
Bystander effects of irradiated media transfer
on neuronal differentiation of NSC
In general, the early radiation-induced bystander response
with the end-point of induction of apoptosis in NSC was
reproducible and convincing, but exhibited a relatively low
consequence at this time point. The next aim of our study
was to determine delayed radiation-induced bystander
effects that could affect neuronal differentiation of NSC in
the cell culture conditions. We used again in our experi-
ments pretreatment of the native NSC with media trans-
ferred from non-irradiated (control) cells and from directly
irradiated NSC (24 h after treatment) with the subsequent
induction of neural differentiation of NSC using the spe-
cific differentiation media (see Suppl. Fig. 2). Removing
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Fig. 4 Radiation-induced apoptosis in NSC is mediated by endog-
enous TRAIL/TRAIL-R2 expression. a Total expression levels of
TRAIL-R2 (DR5) and TRAIL 16 h after c-irradiation of NSC.
Specific immunostaining and FACS analysis were performed.
b TRAIL levels (pg/ml, normalized for 2 9 106 cells) were detected
in the media 16 h after irradiation of the confluent NSC cultures using
ELISA. Control was a fresh cell-free media. c Dose-dependent
cleavage of PARP1 and its suppression by inhibitory anti-TRAIL Ab
and control IgG that were added to the culture media 30 min before
irradiation. d Effects of anti-TRAIL Ab (50 lg/ml) in the culture
media on increased survival of NSC after irradiation. Cells were
immunostained using anti-Nestin Ab. e Effects of anti-TRAIL Ab and
control nonspecific IgG on levels of radiation-induced apoptosis 48 h
after treatment. Pooled results of four independent experiments are
shown. Error bars represent mean ± SD (p \ 0.05, Student’s t test);
star indicates a significant difference. f Radiation-induced changes in
surface expression of Fas and total expression of Fas-L in NSC 16 h
after irradiation (5 Gy). US mean unstained cells
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differentiation of human NSC (Fig. 6; Control-1 cells) that
was accompanied by high levels of precursor cell death
during differentiation. The gradual disappearance of an early
neuroprogenitor cell marker, Nestin (red), which was
substituted with a neuronal marker, Doublecortin (green)
was evident in surviving cells (Fig. 6). Gamma-irradiation
before induction of differentiation significantly retarded this
process with a strong decrease in a green/red ratio (a ratio of
the number of Doublecortin-positive green cells to the
number of Nestin-positive red cells that reflected the degree
of neuronal differentiation) and in a relative cell survival.
Relative cell survival after differentiation of control or
irradiated cells was determined by direct counting cells that
were attached to the laminin matrix in six microscopic areas
10 days after initiation of differentiation. Media transfer
from irradiated NSC (24 h after irradiation) to naive
bystander NSC affect cell survival, compared to non-
irradiated media transfer to control-2 cells and decreased the
ratio of green Doublecortin-positive young neurons among
differentiating cells (Fig. 6d). Non-specific IgG did not
change the dramatic effects of direct irradiation of NSC
while a pretreatment with anti-TRAIL antibody (50 lg/ml)
added to media before irradiation of NSC, partially reversed
inhibition of survival and differentiation (Fig. 6c). Anti-
TRAIL pretreatment notably, but still modestly increased
the yield of young neurons among bystander cells (Fig. 6f).
On the other hand, direct pretreatment with exogenous
recombinant TRAIL (10–50 ng/ml for 8 h) negatively
affected the final yield of young neurons after differentiation
in a dose-dependent manner (Fig. 7). The entire NSC pop-
ulation contained three sub-populations with higher, lower
and negative surface expression of TRAIL-R2 (Fig. 7a).
TRAIL-R-high NSC (with 110 MFI) could quickly die after
TRAIL pretreatment during differentiation. However, at least
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Fig. 5 Radiation-induced bystander effects in NSC: cell cycle and
apoptosis analysis of directly irradiated and non-targeted cells. a,
b NSC were irradiated at 5 Gy. 24 h after irradiation, the media from
irradiated and control (non-irradiated) cells were transfer to naive
NSC, which were cultured for additional 24 or 48 h. Cell cycle-
apoptosis analysis was performed for directly irradiated cells 48 and
72 h after irradiation (the left part of a and b) and for non-targeted
cells 24 and 48 h after media transfer (the right parts of a and b).
c Analysis of PARP1 cleavage was performed for control and
bystander cells 24 and 48 h after media transfer. d–f Similar
experiments were performed with media transfer from control (non-
irradiated) and directly irradiated immortalized human fetal astrocyte
(IHFA) to NSC. Cell cycle apoptosis analysis is shown on d and e;
Western blot analysis of PARP1 is shown on f
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some of the TRAIL-R-low or TRAIL-R-negative cells might
overcome this treatment and perform neuronal differentiation
(Fig. 7b). Taken together, these observations highlight a role
for TRAIL in radiation-induced apoptosis of neural stem/
progenitor cells. Inhibition of TRAIL significantly increased
survival of differentiating cells, especially, for directly irra-
diated NSC and upregulated the degree of neuronal differ-
entiation of both directly irradiated and bystander NSC.
Radiation-induced signaling pathway and radiation-
induced apoptosis in SK-N-SH human neuroblastoma
cells
To further highlight the effects of intercellular communi-
cation after ionizing irradiation, we performed experiments
with direct irradiation of cancer cells (human SK-N-SH
neuroblastoma) trying to evaluate the induction of a
bystander response in non-targeted NSC by signals from
irradiated cancer cells. The primary neuroblastomas are
characterized by a neural crest origin and extracranial
location; however, highly metastatic neuroblastomas can
go to the brain [22, 23] and potentially affect NSC. Even
non-treated SK-N-SH neuroblastoma cells produce and
secrete elevated levels of several cytokines, such as IL6,
TNFa, TGFb1, and COX-2-driven prostaglandin-E2 that
could be found in cell cultures [24–27]. We therefor
expected to detect potentially strong radiation-induced
signal transmission from directly irradiated neuroblastoma
cells to non-targeted NSC.
Dose-dependent effect of direct c-irradiation on the
main signaling pathways was really dramatic in SK-N-SH
neuroblastoma cells (Fig. 8a, b), compared to NSC (see
Fig. 2a). It includes stabilization of p53 protein levels and
upregulation of p53-dependent BAX, TRAIL and DR5
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Fig. 6 Neuronal differentiation of NSC in culture: bystander effect as
a result of irradiated media transfer. a–c NSC were non-treated
(Control-1) or directly c-irradiated at 5 Gy. d–f NSC were primed by
24 h-incubation with transferred media from non-irradiated cells
(Control-2) or from irradiated NSC (Bystander cells). Neuronal
differentiation of non-irradiated (Control-1), directly irradiated NSC
and primed non-targeted NSC (Control-2 and Bystander) was initiated
by differentiation media. Furthermore, non-specific IgG (b, e) or
inhibitory anti-TRAIL Ab (50 lg/ml) (c, f) were added 30 min before
irradiation to indicated cultures and were maintained for the next
24 h, before neuronal differentiation was initiated. Confocal analysis
of immunofluorescent images was performed using monoclonal Ab
against an early neuroprogenitor marker, Nestin (red), and polyclonal
Ab against a neuronal marker, Doublecortin (green). A ratio of the
number of green cells to the number of red cells and relative cell
survival for irradiated cells 10 days after initiation of differentiation
are indicated
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levels, activation of NF-jB p65, MAPK p38, ERK and
upregulation of JNK2 activity (at 2.5–5 Gy) in neuroblas-
toma cells (Fig. 8a, b). A modest downregulation of high
constitutive levels of P-JNK and P-AKT could be detected
in neuroblastoma cells after irradiation at 10 Gy. Endoge-
nous TGFb1 production was gradually decreased following
irradiation, while TGFb-R2 levels were upregulated
(Fig. 8b). Caspase-8 activation was not detectable, a
modest down-regulation of the latent pro-Caspase-3 was
evident only 6 h after treatment at 10 Gy; however,
PARP1-clevage was still very slight at this time point.
Levels of anti-apoptotic Survivin were also decreased,
while XIAP levels were stable after irradiation (Fig. 8b). A
notable, but still modest increase in total expression of
TRAIL and pronounced increase in surface expression of
DR5 were also detected after irradiation of neuroblastoma
cells using immunostaining and FACS analysis (Fig. 8a, c).
However, radiation-induced apoptosis was not really
detectable 16–24 h after irradiation of SK-N-SH cells,
reflecting a strong prevalence of surviving functions.
The exogenous TRAIL at high dose (50 ng/ml) alone or
in combination CHX induced low levels of apoptosis 16 h
after treatment (Fig. 8d). However, c-radiation pretreat-
ment in combination with the exogenous TRAIL induced
higher levels of apoptosis, due to a notable upregulation of
TRAIL-R2 surface expression in irradiated neuroblastoma
cells (Fig. 8c). Taken together, these observations dem-
onstrate a modest level of endogenous TRAIL expression
and efficient anti-apoptotic protection that suppressed
radiation-induced apoptosis in SK-N-SH cells at the early
time points. Consequently, higher levels of radiation-
induced apoptosis of neuroblastoma cells were observed
only 72 h after treatment with 10 Gy (Suppl. Fig. 2A, B).
On the other hand, the use of small molecule inhibitors of
the protective signaling pathways, IKK-NF-jB, Stat3 or
PI3K–AKT, in combination with radiation allowed us to
dramatically increase induction of apoptosis, even at the
early time points (Suppl. Fig. 2A). Additionally, suppres-
sion of endogenously produced TGF-b1 in cell media by
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Fig. 7 Dose-dependent effects of the exogenous TRAIL on death and
differentiation of NSC. a The whole population of NSC contained
three subpopulations with negative (ns), lower (14 MFI) and higher
(110 MFI) levels of surface TRAIL-R2 expression determined by
immunostaining and FACS analysis. b, c NSC were pretreated for 8 h
by increased doses of the exogenous TRAIL (10–50 ng/ml). Next, the
neuronal differentiation of NSC was induced by changing to
differentiation media. Three repeats of representative images of the
neuronal differentiation of the control and TRAIL-treated cells are
shown (after 10 days of culture in differentiation media) in b. The
pooled results of three independent experiments are shown in c. Error
bars represent mean ± SD (p \ 0.05, Student’s t test); star indicates
a significant difference
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radiation-induced apoptosis in neuroblastoma cells, high-
lighting anti-apoptotic function of TGFb signaling in
neuroblastoma cells (Fig. 8e), as it was recently observed
for glioblastoma cells [28].
Radiation-induced effects of SK-N-SH neuroblastoma
cells on cell cycle and apoptosis of non-targeted NSC
Even though, SH-N-SH cells did not develop apoptosis 16–24
after irradiation (Fig. 9a, c), media transfer experiments to non-
targeted native NSC induced detectable levels of apoptosis in
NSC that was clearly different from the basal levels. Addi-
tionally, PARP1 cleavage was observed in bystander NSC
under these conditions (Fig. 9c, the right side). Media transfer
from both control and irradiated neuroblastoma cells 48 h after
treatment to non-targeted NSC induced pronounced apoptosis,
although with a significant increase in apoptotic levels in NSC
treated with irradiated media (Fig. 9b, c). This reflects the
presence of death-inducing factors in the media of non-treated
neuroblastoma cells that are increased after irradiation. Indeed,
pretreatment with anti-TRAIL Ab of both control and irradi-
ated media from SK-H-SH cells substantially (but not com-
pletely) decreased apoptotic levels in the non-targeted NSC
(Fig. 9d). Taken together, these experiments indicate that high
levels of anti-apoptotic protection in neuroblastoma cells [22]
allowed to avoid the death of the vast majority of cancer cells
after irradiation. However, non-targeted NSC could be quite
efficiently killed by media transfer from control and, especially,
from irradiated neuroblastoma cells.
Radiation-induced effects of SK-N-SH cells
on the neuronal differentiation of non-targeted NSC
As expected, a strong cytotoxic activity of media from non-
irradiated and, especially, from irradiated neuroblastoma
cells that were used for pretreatment of non-targeted NSC
before initiation of differentiation caused dramatic sup-
pressive effects on neuronal differentiation. Irradiated media
from neuroblastoma cells finally killed the vast majority of
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Fig. 8 Radiation-induced proapoptotic and antiapoptotic signaling
pathways in SK-N-SH human neuroblastoma cells. a, b Western blot
analysis of indicated proteins 6 h after treatment with increasing
doses of c-irradiation. c TRAIL-R2/D5 surface expression was
determined in directly irradiated SK-N-SH cells by immunostaining
and FACS analysis. d Effect of c-irradiation (5 Gy) on TRAIL-
induced apoptosis of SK-N-SH cells. Error bars represent
mean ± SD (p \ 0.05, Student’s t test); star indicates a significant
difference. e Effects of inhibitory anti-TGFb1 Ab on radiosensitivity
of SK-N-SH cells. Vehicle solution, 0.1 % DMSO, and zVAD-fmk
(40 lM) were used. Error bars represent mean ± SD (p \ 0.05,
Student’s t test); star indicates a significant difference
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(Fig. 10, the upper panel). The presence of anti-TRAIL
antibody increased a survival of differentiating cells for both
types of media transfer, although effect of anti-TRAIL on
restoring neuronal differentiation was relatively modest
(Fig. 10, the bottom panel). In summary, these observations
indicated that TRAIL produced by cancer cells might be
involved in modulating cell death and suppression of neu-
ronal differentiation of non-targeted NSC. However, this
death ligand appears to operate in a complex combination
with other cytotoxic and protective factors, such as Fas-L,
IL6, TNFa and TGFb1 produced by cancer cells that also
could affect NSC survival and differentiation.
Discussion
Results of our study demonstrated that radiation-induced
apoptosis of NSC in cell culture is mainly mediated by
TRAIL/TRAIL-R2 interaction through autocrine or para-
crine stimulation. This finding is in contrast to the popular
belief that this signaling mechanism preferentially kills
cancer cells. Indeed, the vast majority of cancer cell lines
express TRAIL-receptors and approximately 50 % of these
lines can efficiently induce the TRAIL-R-death signaling
cascade after treatment by exogenous TRAIL. In contrast,
other lines require an additional co-treatment for the
induction of TRAIL-dependent death, such as inhibition of
PI3K–AKT or NF-jB signaling pathways [29, 30]. The
exogenous TRAIL in vivo can be produced at low levels by
many types of TRAIL-R-negative normal cells and at
higher levels by some types of cells of the immune system.
Recombinant TRAIL or anti-TRAIL-R agonistic antibodies
were used with variable success to kill different types of
cancer cells [31]. Radiation-induced stimulation of TRAIL
production in TRAIL-R-positive NSC, however, could be
an additional complication on the use of radiation therapy
to specifically kill cancer cells. Paradoxically, human NSC
with ectopic overexpression of the membrane form of
TRAIL were successfully used as a vehicle for delivery of
a death ligand to glioblastoma xenotransplant in animal
experiments with the subsequent induction of apoptosis (in
combination with bortezomib) [32]. We think, however,
that effective protection of the endogenous human NSC
against membrane TRAIL, which is delivered by vehicle
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Fig. 9 Bystander effects of directly irradiated SK-N-SH cells on the
neural differentiation of non-targeted NSC. a, b Media transfer from
control (non-irradiated) and c-irradiated SK-N-SH cells 24 and 48 h
after irradiation to non-targeted naive NSC. Results of cell cycle-
apoptosis analysis are shown 24–48 h for directly irradiated cells and
24 h after media transfer to non-targeted cells. c Western blot analysis
of PARP1 cleavage in directly irradiated SK-N-SH cells (24 h after
irradiation with two independent repeats—1 and 2) and in non-
targeted NSC (24 after media transfer). d Both control and irradiated
media were pretreated with anti-TRAIL Ab (50 lg/ml) before
irradiation. Cell-cycle-apoptosis analysis was performed
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NSC, should be considered in similar type of treatment of
glioblastoma in human.
Human NSC were also sensitive to Fas-L- and, espe-
cially, to TNFa-induced cell death, due to the presence of
the corresponding receptors. TNFa could be produced
in vivo by microglial cells of the brain [18], targeting via
TNFR1 both apoptotic and necrotic pathways in NSC.
While the TNFR1-mediated apoptotic pathway might be
blocked by caspase-3 inhibitors, the TNFR1-mediated
necroptotic pathway was suppressed using RIP1 inhibitor,
Necrostatin-1 [17]. Surprisingly, Necrostatin-1 was dem-
onstrated in the present study as a strong inducer of a
protective AKT activity in NSC (see Fig. 3a) that could
additionally maintain the integrity of mitochondria and
suppress development of oxidative stress. Necrostatin-1
treatment was previously used for efficient suppression of
cell death during ischemic brain injury [33]. On the other
hand, beside induction of cell death, TNFa may serve as a
classical inducer of cell survival pathways via NF-jB
activation. Such complicated functions of TNFa highlights
its central role in balancing between life and death during
different types of stress responses [34–36]. An additional
possibility for negative regulation of NSC survival was
linked with Fas-L production by cancer cells with the
simultaneous radiation-induced upregulation of Fas-
Receptor levels in NSC and down-regulation of antiapo-
ptotic protein regulators. Similarly with TNFR-signaling,
Fas-Receptor-mediated signaling cascades could be either
proapoptotic, or prosurvival, due to numerous regulatory
mechanisms, including NF-jB activation by this pathway
[15]. Prosurvival features of Fas-Receptor pathway are
probably well pronounced in mouse NSC/NPC [37].
In general, ionizing irradiation of cells targets numerous
cell signaling pathways and induces changes in expression
of several hundred genes [38]. However, radiation-induced
gene activation shares some common features with other
types of cell stress, including modulation of the pro-
inflammatory and anti-inflammatory gene expression of
specific sets of cytokines and their receptors, COX2
expression and COX2-directed production of PGE2,
expression of death ligands and death receptors [9, 39] (see
Suppl. Fig. 4). Production and secretion of cytokines and
PGE2 after irradiation may serve as a basis for induction of
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Fig. 10 Effects of media
transfer from non-irradiated and
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on neuronal differentiation of
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We and others previously observed radiation-induced
induction/upregulation of COX2 gene expression in normal
embryonic fibroblasts [40] and cancer cells, such as neu-
roblastoma, glioblastoma and melanoma [25, 41], and
demonstrated a significant role of COX2-PGE2 signaling
pathway in regulation and propagation of the bystander
response [40, 42]. Surprisingly, we did not detect high
levels of inducible COX2 expression in NSC. However, the
bystander effect in these cells could be modulated by dis-
tinct signaling transmitters, including TRAIL (see Suppl.
Fig. 4). We previously demonstrated that oxidative stress
induced by sodium arsenite treatment of NSC resulted in
activation of the inner mitochondrial death pathway
accompanied by high levels of death of NSC and sup-
pression of neuronal differentiation [43]. Interestingly,
radiation-induced apoptosis of NSC, which was mediated
mainly by the TRAIL/TRAIL-R2 apoptotic pathway in
concert with additional regulators of cell survival, also
suppressed neuronal differentiation. Furthermore, bystan-
der suppression of NSC differentiation was especially
strong in case of radiation-induced intercellular commu-
nication between irradiated cancer (neuroblastoma or
glioblastoma) cells and NSC. We expect that further
investigations of mechanisms of radiation-induced neuro-
toxicity at the level of human NSC may open new oppor-
tunities to protect and maintain neurogenesis after anti-
cancer therapy, especially for patients with brain tumors.
Materials and methods
Materials
Fibronectin, laminin, polyornithine and prostaglandin E2
(PGE2) were obtained from Sigma-Aldrich (St. Louis, MO,
USA). PI3K inhibitor LY294002, IKK inhibitor BMS-
345541, STAT3 inhibitor-6 S3I-201 (also known as NSC
74859), PI3K inhibitor LY294002, MEK inhibitor U0126,
MAPK p38 inhibitor SB203580, JNK inhibitor SP600125
and pan-caspase inhibitor zVAD-fmk was purchased from
Calbiochem (La Jolla, CA, USA). Necrostatin-1, a RIP-1
inhibitor, was obtained from EMD Millipore (Billerica,
MA, USA). Human soluble Killer-TRAIL (recombinant)
and Fas-L (recombinant) were purchased from Alexis (San
Diego, CA, USA); human TNFa, TGFb1, IL1b and IL6
were obtained from R&D Systems (Minneapolis, MN,
USA).
Human embryonic NSC in culture
Cryopreserved human embryonic NSC were obtained from
Gibco/Life Technologies (Carlsbad, CA, USA) as a com-
mercially available product (N7800-200). The cells were
derived from NIH approved H9 (WA09) human embryonic
stem cells. The cells were plated in 6-well culture plates
coated with fibronectin and incubated at 37 C in complete
growth medium NSC/SFM, which contained serum-free
DMEM/F12 supplemented with 2 mM GlutaMAX, bFGF
(20 ng/ml), EGF (20 ng/ml) and StemPRO neural supple-
ment (2 %). All reagents were obtained from from Gibco/
Life Technologies (Carlsbad, CA, USA).
Neuronal differentiation of human NSC in culture
NSC were plated on polyornithine- and laminin-coated
6-well plates, which contained similarly coated cover slips,
in complete NSC/SFM. After 2 days, neuronal differenti-
ation was initiated by neuronal differentiation media,
which contains Neurobasal medium, B-27 Serum-free
supplement (2 %) and 2 mM GlutaMAX (Gibco/Life
Technologies). Medium was changed every two days. A
neuronal phenotype was confirmed using immunofluores-
cence detection 10 days after initiation of differentiation.
Cell lines
IHFA were kindly provided by Dr. M. Davidson (Columbia
University, New York, NY, USA). Human neuroblastoma
SK-N-SH (HTB-11, ATCC) and human glioblastoma
(HTB-14, ATCC) cell lines were obtained from ATCC
(Manassas, VA, USA).
Immunocytochemistry analysis
Cells were fixed with 4 % paraformaldehyde in PBS for
60 min. Immunochemical staining was performed using
standard protocols. Cells were stained for the undifferen-
tiated NSC marker, Nestin (using mAb from Millipore,
Temecula, CA, USA) and for the neuronal marker, Dou-
blecortin using Ab from Cell Signaling, (Danvers, MA,
USA). Additional markers include Sox2 and phospho-JNK
(using Abs from Cell Signaling). The secondary Abs were
Alexa Fluor 594 goat anti-mouse IgG and Alexa Fluor 488
goat anti-rabbit IgG from Molecular Probes/Life Technol-
ogies (Carlsbad, CA, USA). A laser scanning confocal
microscope (Nikon TE 2000 with EZ-C1 software, Tokyo,
Japan) was used for immunofluorescence image analysis.
Irradiation procedures
To determine sensitivity to c-rays, plated NSC, astrocytes,
neuroblastoma and glioblastoma cells were exposed to
radiation from a Gammacell 40 137Cs irradiator (dose rate,
0.82 Gy/min) at Columbia University. 6–72 h after irradi-
ation, cells were stained with PI and analyzed by flow
cytometry.
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FACS analysis of TRAIL, TRAIL-R2/DR5, TRAIL-
R1/DR4, Fas and Fas-L levels
Total and surface levels of TRAIL, TRAIL-R2/DR5,
TRAIL-R1/DR4, Fas and Fas-L on human cell lines were
determined by staining with a PE-conjugated anti-human-
TRAIL, anti-human-DR5, anti-human-DR4, anti-human
Fas and anti-human-Fas-L mAbs (R&D System, Minne-
apolis, MN, USA and eBioscience, San Diego, CA, USA)
and subsequent flow cytometry. For detection of total
levels of antigen proteins, cells were fixed and permeabi-
lized using 0.5 % Triton X-100 in PBS. PE-conjugated
nonspecific mouse IgG1 was used as an immunoglobulin
isotype control. A FACS Calibur flow cytometer (Becton–
Dickinson, Mountain View, CA, USA) and the CellQuest
program were used to perform flow cytometric analysis.
All experiments were independently repeated 3–5 times.
Apoptosis studies
For induction of apoptosis, cells were exposed to c-irra-
diation (2–10 Gy) alone or in the presence of small mol-
ecule inhibitors of cell signaling pathways. Furthermore,
apoptosis was induced TRAIL, TNFa, Fas-L, TGFb and
CHX alone or in combination. Apoptosis was then assessed
by PI staining and quantifying the percentage of hypodip-
loid nuclei (pre-G1) using FACS analysis that was per-
formed on a FACS Calibur flow cytometer (Becton–
Dickinson) using the CellQuest program. Trypan blue
exclusion test was used for determination of cell viability
and total death levels.
Western blot analysis
Total cell lysates (50 lg protein) were resolved on SDS-
PAGE, and processed according to standard protocols. The
monoclonal antibodies used for Western blotting included:
anti-b-Actin (Sigma, St. Louis, MO, USA); anti-caspase-8,
anti-caspase-3 (Cell Signaling, Danvers, MA, USA); The
polyclonal antibodies used included anti-phospho-p44/p42
MAP kinase (T202/Y204) and anti-p44/p42 MAP kinase;
anti-phospho-JNK and anti-JNK1-3; anti-phospho-cJun
(S73) and anti-cJun; anti-phospho-AKT (S473) and anti-
AKT; anti-phospho-p65 (S536) NF-jB and anti-p65 NF-
jB, anti-phospho-STAT3 (Y705) and anti-STAT3; anti-
p53, anti-Bax, anti-b-Catenin, anti-Sox2, anti-Nanog, anti-
TGF-b, anti-TGF-b-Receptor-2 and anti-PARP-1 (Cell
Signaling, Danvers, MA, USA); anti-Fas, anti-Fas-L, anti-
DR5/TRAIL-R2, anti-DR4/TRAIL-R1 and anti-TRAIL
(Alexis, San Diego, CA, USA); anti-Survivin (R&D, USA)
The secondary antibodies were conjugated to horseradish
peroxidase; signals were detected using the ECL system
(Thermo Scientific, Rockford, IL, USA).
ELISA for TRAIL detection in the media
Antibody pair used in sandwich ELISA for detection of
human TRAIL was from R&D System (Minneapolis, MN,
USA).
Statistical analysis
Data from four to five independent experiments were cal-
culated as means and standard deviations. Comparisons of
results between treated and control groups were made by
the Student’s t tests. A p value of 0.05 or less between
groups was considered significant.
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